Executive Director, Drug Metabolism
Gilead Sciences, Inc.
Dr. Lai is a Sr. Director of Drug Metabolism at Gilead Sciences, AAPS fellow and Adjunct Faculty in the Department of Pharmacy of the University of Rhode Island. His current role in Gilead is to manage in vitro labs and implement preclinical/clinical strategies for compound advancement to regulatory filing. He received his M.D from Fujian Medical University in China and his Ph.D. (Toxicology) from Sapporo Medical University in Japan in 1998. Prior to joining Glread, Dr. Lai led research programs at Pfizer and BMS in transporter research and ADME-PK-Tox. He is the associate editor/editorial board members of top ranking DMPK journals inlcuding DMD, BDD, JPS and Frontier Pharmacology etc. He published a book, book chapters and over 150 original publications.